| Dr Duane Michael Tippets, DO | |
|
731 Leighton Ave, Suite 300, Anniston, AL 36207-5761 | |
| (256) 236-4121 | |
| (256) 237-5254 |
| Full Name | Dr Duane Michael Tippets |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 18 Years |
| Location | 731 Leighton Ave, Anniston, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093011991 | NPI | - | NPPES |
| 511-27255 | Other | AL | BLUE CROSS BLUE SHIELD OF ALABAMA |
| 141206 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | DO1260 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anniston Orthopedics Associates Pa | 3870495294 | 11 |
| Southern Orthopaedic Alliance Pllc | 2365800604 | 50 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin has developed AI-based software that regularly evaluates all monitoring data and alerts staff before a critical situation is reached.
Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology.
Could certain types of hormonal contraceptives cause an increase in seizures in women with epilepsy? A recent Texas A&M Health Science Center study suggests that ethinyl estradiol, the primary component of oral contraceptives, could be detrimental to the epileptic brain.
A new, implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients, according to lead researcher Dr. William Abraham of The Ohio State University Wexner Medical Center.
› Verified 7 days ago
| Entity Name | Anniston Orthopedics Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366636706 PECOS PAC ID: 3870495294 Enrollment ID: O20040124000279 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin has developed AI-based software that regularly evaluates all monitoring data and alerts staff before a critical situation is reached.
Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology.
Could certain types of hormonal contraceptives cause an increase in seizures in women with epilepsy? A recent Texas A&M Health Science Center study suggests that ethinyl estradiol, the primary component of oral contraceptives, could be detrimental to the epileptic brain.
A new, implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients, according to lead researcher Dr. William Abraham of The Ohio State University Wexner Medical Center.
› Verified 7 days ago
| Entity Name | Southern Orthopaedic Alliance Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588364228 PECOS PAC ID: 2365800604 Enrollment ID: O20230620001264 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin has developed AI-based software that regularly evaluates all monitoring data and alerts staff before a critical situation is reached.
Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology.
Could certain types of hormonal contraceptives cause an increase in seizures in women with epilepsy? A recent Texas A&M Health Science Center study suggests that ethinyl estradiol, the primary component of oral contraceptives, could be detrimental to the epileptic brain.
A new, implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients, according to lead researcher Dr. William Abraham of The Ohio State University Wexner Medical Center.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Duane Michael Tippets, DO 731 Leighton Ave, Suite 300, Anniston, AL 36207-5761 Ph: (256) 236-4121 | Dr Duane Michael Tippets, DO 731 Leighton Ave, Suite 300, Anniston, AL 36207-5761 Ph: (256) 236-4121 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin has developed AI-based software that regularly evaluates all monitoring data and alerts staff before a critical situation is reached.
Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology.
Could certain types of hormonal contraceptives cause an increase in seizures in women with epilepsy? A recent Texas A&M Health Science Center study suggests that ethinyl estradiol, the primary component of oral contraceptives, could be detrimental to the epileptic brain.
A new, implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients, according to lead researcher Dr. William Abraham of The Ohio State University Wexner Medical Center.
› Verified 7 days ago
Duane Dickie Tippets, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave, Suite 300, Anniston, AL 36207 Phone: 256-236-4121 Fax: 256-237-5254 | |
John Richard Payne, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 731 Leighton Ave, Suite 300, Anniston, AL 36207 Phone: 256-236-4121 Fax: 256-237-5254 | |
Michael Roger Wiedmer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave, Suite 300, Anniston, AL 36207 Phone: 256-236-4121 Fax: 256-237-5254 | |
Gordon Townsend Hardy, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave, Suite 300, Anniston, AL 36207 Phone: 256-236-4121 Fax: 256-237-5254 | |
Andrew Charles Morris, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave Ste 300, Anniston, AL 36207 Phone: 850-916-3700 | |
Dr. Morton Sumner Rickless, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 716 E 10th St, Suite B, Anniston, AL 36207 Phone: 256-238-9500 Fax: 256-238-9524 |